Interventional News

Interventional News serves as a comprehensive hub for news and insights in the fields of endovascular procedures and interventional oncology, available both online and in print. It provides coverage of important conferences and journals related to interventional practices. The print edition of the newspaper is distributed to more than 8,000 professionals every three months.

International, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#2521563

United States

#963573

Health/Medicine

#5597

Traffic sources

Monthly visitors

Articles

Transcatheter arterialisation of the deep veins: Comparative analysis probes whether emerging modality is worth pursuing

2 weeks ago | interventionalnews.com | Eva Malpass

“We’re living in a new world order” when it comes to “no-option” chronic limb-threatening ischaemia (CLTI) patients, says Anahita Dua (Massachusetts General Hospital, Boston, USA). In recent years, into this arena has stepped transcatheter arterialisation of the deep veins (TADV), raising hopes of reducing amputation rates amid a rise in diabetes and other disease affecting microvascular dissemination.
HistoSonics's #HOPE4KIDNEY trial completes patient enrolment

2 weeks ago | interventionalnews.com | Eva Malpass

HistoSonics has announced that it has completed enrolment in a pivotal trial to evaluate its histotripsy platform in treating kidney tumours. The US company’s prospective, multicentre, single-arm pivotal #HOPE4KIDNEY trial is designed to evaluate the effectiveness and safety of the Edison system for the destruction of kidney tissue by treating primary solid renal tumours. A total of 67 patients have been enrolled with a single, non-metastatic solid kidney mass ≤3cm.
Penumbra receives US FDA clearance for Ruby XL system

3 weeks ago | interventionalnews.com | Eva Malpass

Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of the Ruby XL system. The Ruby XL system is designed to help physicians achieve more efficient embolization, potentially reducing radiation exposure, and optimizing outcomes—especially in large vessel and high-flow embolization, details a recent company press release.
TriSalus Life Sciences launches the TriNav FLX infusion system - Interventional News

3 weeks ago | interventionalnews.com | Eva Malpass

TriSalus Life Sciences has announced the launch of the TriNav FLX infusion system. The TriNav FLX infusion system retains the same trusted pressure-enabled drug delivery (PEDD) benefits as existing products but introduces an important advancement in design, states a recent company press release. The new system features twice the length of flexible material at the distal end, allowing for easier navigation through more tortuous vessels.
Which embolic to use during portal vein embolization

3 weeks ago | interventionalnews.com | Eva Malpass

Portal vein embolization (PVE) is a crucial preoperative procedure designed to induce hypertrophy of the future liver remnant (FLR) in patients requiring major hepatectomy. Among the embolic agents available, n-butyl cyanoacrylate (nBCA) combined with lipiodol has emerged as one of the most effective options for PVE, shares José Hugo Luz (Brazilian National Cancer Institute, Rio de Janeiro, Brazil), promoting a high yield of liver hypertrophy and requires only a minimal volume of contrast media.
MRI-guided ablation for the treatment of prostate cancer, successes and pitfalls

3 weeks ago | interventionalnews.com | Eva Malpass

With a focus on magnetic resonance imaging (MRI)-guided procedures and cancer signalling pathways which promote cancer resistance to ablation, David Woodrum (Mayo Clinic, Rochester, USA) discusses how advancements in MRI have solidified its place in the diagnosis and treatment of prostate cancer. Focal prostate ablation continues to challenge the standard paradigm for prostate cancer treatment.
FastWave Medical announces successful 30-day first-in-human data on Sola IVL technology

3 weeks ago | interventionalnews.com | Eva Malpass

FastWave Medical has announced the successful completion of initial first-in-human (FIH) procedures in its feasibility study of Sola, the coronary laser intravascular lithotripsy (IVL) system. The multicentre study will assess Sola’s safety and performance in patients with calcified coronary artery disease. Sola is a rupture-resistant balloon catheter designed to help physicians treat hardened calcium in blood vessels with precision and control.
Renal cell carcinoma mimicking pseudoaneurysm post cryoablation

1 month ago | interventionalnews.com | Eva Malpass

What should be done if a cryoablation of renal cell carcinoma (RCC) is performed successfully but follow-up imaging demonstrates a possible pseudoaneurysm? Here, Nassir Rostambeigi (Mallinckrodt Institute of Radiology, St Louis, USA) shares details of a case in an attempt to answer this question. Renal cryoablation is a well-established technique for treating renal masses, offering comparable outcomes to partial nephrectomy while minimising morbidity.
Major gaps in IR knowledge must be addressed

1 month ago | interventionalnews.com | Eva Malpass

In a paper titled ‘Specialist awareness of interventional radiology: Current state of affairs and opportunities for improvement’, Mina S Makary (Columbus, USA) and his team surveyed specialist provider understanding of interventional radiology (IR) at their tertiary centre, which yielded unanticipated results. Here, he discusses the data they collected and their broader significance for the evolution of the specialty.
Geographic information mapping identifies IR expansion opportunities to combat postpartum haemorrhage in Kenya

1 month ago | interventionalnews.com | Eva Malpass

A new geographic information system (GIS) analysis of Kenya has found “disproportionate” rates of maternal morbidity and mortality due to postpartum haemorrhage (PPH) in areas without interventional radiology (IR) capabilities.